![glp-1 7-36 Oral l-glutamine increases active (7-36) amide secretion and improves glycemic control in stretpozotocin–nicotinamide induced diabetic rats 36) in Heparin Plasma Characterization of [125I]GLP-1(9-36), a novel](https://ars.els-cdn.com/content/image/1-s2.0-S0009279713000409-fx1.jpg)
glp-1 7-36 Oral l-glutamine increases active (7-36) amide secretion and improves glycemic control in stretpozotocin–nicotinamide induced diabetic rats 36) in Heparin Plasma Characterization of [125I]GLP-1(9-36), a novel
USD27.07
USD76.07
Pay in 4 interest-free payments of $6.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
![glp-1 7-36 Oral l-glutamine increases active (7-36) amide secretion and improves glycemic control in stretpozotocinnicotinamide induced diabetic rats 36) in Heparin Plasma Characterization of [125I]GLP-1(9-36), a novel](https://ars.els-cdn.com/content/image/1-s2.0-S002432051400335X-gr2.jpg)
![glp-1 7-36 Oral l-glutamine increases active (7-36) amide secretion and improves glycemic control in stretpozotocinnicotinamide induced diabetic rats 36) in Heparin Plasma Characterization of [125I]GLP-1(9-36), a novel](https://content.abcam.com/products/images/human-glp1-7-36-antibody-pair-bsa-and-azide-free-ab243974--sandwich-elisa-img185602.jpg)
![glp-1 7-36 Oral l-glutamine increases active (7-36) amide secretion and improves glycemic control in stretpozotocinnicotinamide induced diabetic rats 36) in Heparin Plasma Characterization of [125I]GLP-1(9-36), a novel](https://www.alpco.com/media/wysiwyg/GLP-1_7-36_amide_Chemiluminescence_ELISA-cover.jpg)
![glp-1 7-36 Oral l-glutamine increases active (7-36) amide secretion and improves glycemic control in stretpozotocinnicotinamide induced diabetic rats 36) in Heparin Plasma Characterization of [125I]GLP-1(9-36), a novel](https://figures.semanticscholar.org/a76baea6338285d73e83cf193eb78e3a05a53212/2-Figure2-1.png)
